Inventor
SAMPATH KUBER T
US46 patents
⚠️ This page may combine multiple inventors who share the name “SAMPATH KUBER T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
STRYKER CORP
13 patentsUS6504079B2Jan 7, 2003
Terminally sterilized osteogenic devices and preparation thereof
STRYKER CORP92 citations99
US6027743AFeb 22, 2000
Manufacture of autogenous replacement body parts
STRYKER CORP168 citations99
US5674292AOct 7, 1997
Terminally sterilized osteogenic devices and preparation thereof
STRYKER CORP119 citations99
US6461630B1Oct 8, 2002
Terminally sterilized osteogenic devices and preparation thereof
STRYKER CORP72 citations96
US6028242AFeb 22, 2000
Terminally sterilized osteogenic devices and preparation thereof
STRYKER CORP42 citations96
US6013856AJan 11, 2000
Terminally sterilized osteogenic devices and preparation thereof
STRYKER CORP65 citations96
US6958149B2Oct 25, 2005
Repair of larynx, trachea, and other fibrocartilaginous tissues
STRYKER CORP44 citations95
US7572440B2Aug 11, 2009
Method for repairing a defect in an intervertebral disc
STRYKER CORP26 citations91
US8017580B2Sep 13, 2011
Therapies for chronic renal failure
STRYKER CORP4 citations74
US7524817B2Apr 28, 2009
Therapies for chronic renal failure
STRYKER CORP7 citations72
US8354375B2Jan 15, 2013
Repair of ligament using osteogenic proteins
STRYKER CORP2 citations61
US7803369B2Sep 28, 2010
Devices and method for repair of larynx, trachea, and other fibrocartilaginous tissues
STRYKER CORP2 citations61
US8377878B2Feb 19, 2013
Therapies for chronic renal failure
STRYKER CORP0 citations52
CURIS INC
10 patentsUS6861404B1Mar 1, 2005
Therapies for chronic renal failure
CURIS INC82 citations96
US6498142B1Dec 24, 2002
Morphogen treatment for chronic renal failure
CURIS INC56 citations96
US7147839B2Dec 12, 2006
Methods for evaluating tissue morphogenesis and activity
CURIS INC28 citations93
US6723698B2Apr 20, 2004
Methods and compositions for the treatment of motor neuron injury and neuropathy
CURIS INC29 citations93
US6506729B1Jan 14, 2003
Methods and compositions for the treatment and prevention of Parkinson's disease
CURIS INC32 citations93
US7196056B2Mar 27, 2007
Protein-induced morphogenesis of kidney tissue
CURIS INC6 citations74
US7306903B1Dec 11, 2007
Methods and compositions for identifying morphogen analogs
CURIS INC6 citations62
US7067260B2Jun 27, 2006
Methods of identifying morphogen receptor-binding analogs
CURIS INC4 citations62
US6632618B1Oct 14, 2003
Morphogenic protein-specific cell surface receptors and uses therefor
CURIS INC4 citations62
US6828095B1Dec 7, 2004
Modulators of morphogen expression and methods of identifying the same
CURIS INC0 citations31
CREATIVE BIOMOLECULES INC
10 patentsUS5906827AMay 25, 1999
Matrix for the manufacture of autogenous replacement body parts
CREATIVE BIOMOLECULES INC71 citations96
US5863738AJan 26, 1999
Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides
CREATIVE BIOMOLECULES INC39 citations96
US6273598B1Aug 14, 2001
Computer system and methods for producing morphogen analogs of human OP-1
CREATIVE BIOMOLECULES INC53 citations93
US5968752AOct 19, 1999
Method for identifying an OP-1 analog which binds an ALK-1 receptor
CREATIVE BIOMOLECULES INC27 citations88
US5928940AJul 27, 1999
Morphogen-responsive signal transducer and methods of use thereof
CREATIVE BIOMOLECULES INC31 citations88
US6110460AAug 29, 2000
Methods of using morphogen analogs
CREATIVE BIOMOLECULES INC8 citations74
US6103491AAug 15, 2000
Methods and compositions for identifying morphogen analogs
CREATIVE BIOMOLECULES INC6 citations74
US5932716AAug 3, 1999
Morphogen-responsive regulatory elements
CREATIVE BIOMOLECULES INC8 citations74
US5610021AMar 11, 1997
Compositions and methods for identification and use of soluble complex forms of osteogenic proteins
CREATIVE BIOMOLECULES INC13 citations73
US6090544AJul 18, 2000
Methods and compositions for identifying morphogen analogs
CREATIVE BIOMOLECULES INC6 citations62
GENZYME CORP
4 patentsUS9598486B2Mar 21, 2017
Methods for treating osteogenesis imperfecta
GENZYME CORP6 citations83
US11230595B2Jan 25, 2022
Methods for treating osteogenesis imperfecta
GENZYME CORP2 citations72
US10377819B2Aug 13, 2019
Methods for treating osteogenesis imperfecta
GENZYME CORP3 citations72
US12365725B2Jul 22, 2025
Methods for treating osteogenesis imperfecta
GENZYME CORP0 citations62